Loading...
Valsartan
India Pharmaceutical Trade Intelligence
Who Supplies Valsartan to India from CANADA
India's valsartan imports from CANADA total $29.8K across 48 shipments from 14 foreign suppliers. GLOBYZ PHARMA leads with $11.1K in import value; the top 5 suppliers together control 73.9% of this origin. Leading Indian buyers include ALEMBIC PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for valsartan — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
GLOBYZ PHARMA is the leading Valsartan supplier from CANADA to India, with import value of $11.1K across 13 shipments. The top 5 suppliers — GLOBYZ PHARMA, PHARMACEUTICAL BUYERS ,INC., AdiraMedica Inc, JAMP PHARMA CORPORATION, ADIRAMEDICA INC — collectively account for 73.9% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLOBYZ PHARMA | $11.1K | 13 | 37.3% |
| 2 | PHARMACEUTICAL BUYERS ,INC. | $3.5K | 3 | 11.7% |
| 3 | AdiraMedica Inc | $3.3K | 2 | 11.2% |
| 4 | JAMP PHARMA CORPORATION | $2.1K | 6 | 7.0% |
| 5 | ADIRAMEDICA INC | $2.0K | 1 | 6.8% |
| 6 | PHARMACEUTICAL BUYERS, INC | $1.7K | 2 | 5.8% |
| 7 | NewLife Medicals (USA). Inc. | $1.7K | 3 | 5.8% |
| 8 | TEVA CANADA LIMITED | $997 | 4 | 3.3% |
| 9 | ADIRAMEDICA INC. | $990 | 3 | 3.3% |
| 10 | NEW LIFE MEDICALS USA INC | $973 | 3 | 3.3% |
| 11 | SANDOZ CANADA INC | $969 | 3 | 3.2% |
| 12 | PHARMASCIENCE INC | $245 | 3 | 0.8% |
| 13 | NewLife Medicals (USA). Inc | $122 | 1 | 0.4% |
| 14 | GLOBZY PHARMA | $6 | 1 | 0.0% |
Showing top 14 of 14 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ALEMBIC PHARMACEUTICALS LIMITED | $6.8K | 4 | 22.9% |
| 2 | MYLAN LABORATORIES LIMITED | $3.5K | 3 | 11.7% |
| 3 | DR.REDDY'S LABORATORIES LTD | $3.4K | 6 | 11.5% |
| 4 | MSN LABORATORIES PRIVATE LIMITED | $3.3K | 2 | 11.2% |
| 5 | CLIANTHA RESEARCH LIMITED | $3.3K | 4 | 11.1% |
| 6 | ZYDUS LIFESCIENCES LIMITED | $1.8K | 3 | 6.2% |
| 7 | HETERO LABS LIMITED | $1.7K | 3 | 5.8% |
| 8 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $1.1K | 4 | 3.7% |
| 9 | SANDOZ PRIVATE LIMITED | $969 | 3 | 3.2% |
| 10 | WINDLAS BIOTECH LIMITED | $930 | 3 | 3.1% |
| 11 | LAURUS LABS LIMITED | $828 | 3 | 2.8% |
| 12 | VEEDA CLINICAL RESEARCH LIMITED | $586 | 1 | 2.0% |
| 13 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $436 | 2 | 1.5% |
| 14 | TEVAPHARM INDIA PRIVATE LIMITED | $362 | 1 | 1.2% |
| 15 | LAURUS LABS LTD | $245 | 3 | 0.8% |
Import Statistics
- Import Value
- $29.8K
- Shipments
- 48
- Foreign Suppliers
- 14
- Indian Buyers
- 15
- Avg. Shipment
- $622
Other Valsartan Import Origins
Related Analysis
Frequently Asked Questions — Valsartan Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Valsartan suppliers from CANADA to India?
The top Valsartan suppliers from CANADA to India include GLOBYZ PHARMA, PHARMACEUTICAL BUYERS ,INC., AdiraMedica Inc. The leading supplier is GLOBYZ PHARMA with import value of $11.1K USD across 13 shipments. India imported Valsartan worth $29.8K USD from CANADA in total across 48 shipments.
QHow much Valsartan does India import from CANADA?
India imported Valsartan worth $29.8K USD from CANADA across 48 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Valsartan from CANADA?
The main Indian buyers of Valsartan sourced from CANADA include ALEMBIC PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD. The largest buyer is ALEMBIC PHARMACEUTICALS LIMITED with $6.8K in imports across 4 shipments.
QWhat is the total value of Valsartan imports from CANADA to India?
The total value of Valsartan imports from CANADA to India is $29.8K USD, across 48 shipments and 14 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Valsartan.
- 2.Supplier/Buyer Matching: 14 foreign suppliers from CANADA and 15 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $29.8K aggregated from 48 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
48 Verified Shipments
14 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists